US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 18.910
  • -0.030-0.16%
Close Feb 28 16:00 ET
  • 18.910
  • 0.0000.00%
Post 16:20 ET
2.38BMarket Cap-3.67P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Q1 2025 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.05M
2.50M
-16.55M
Miss Est.
+436.47%
-29.60%
-86.88%
EPS
-0.38
-1.39
-1.01
Miss Est.
+69.26%
-12.10%
-264.64%
Buy

Feb 28, 2025

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    70.00%
  • Hold

    30.00%
  • Sell

    0.00%

Price Target

No Data